Mabala, Cristina C.
HRN: 22-59-42 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2023
CEFUROXIME 1.5GM (VIAL)
10/11/2023
10/11/2023
IV
1.5 Grams
Q8
For Stat CS
Waiting Final Action
10/11/2023
CEFUROXIME 500MG (TAB)
10/11/2023
10/12/2023
PO
500mg
BID
S/p NSVD W/ Perineal Laceration
Checking Final Appropriateness